IDEXX Laboratories Sees Leadership Transition and Shareholder Approval
Company Announcements

IDEXX Laboratories Sees Leadership Transition and Shareholder Approval

Idexx Laboratories (IDXX) has shared an announcement.

IDEXX Laboratories, Inc. has entered into a one-year Consulting Agreement with recently retired Executive Vice President James F. Polewaczyk, effective May 7, 2024. Polewaczyk will be providing coaching and professional development to company employees for $25,000 per month, with the option for renewal. Additionally, at the 2024 Annual Meeting, shareholders voted on various proposals, including the election of directors, ratification of the company’s accounting firm, executive compensation, and a proposal on simple majority voting. All proposals were passed with a significant majority, indicating shareholder support for the current direction of the company’s governance and management.

For a thorough assessment of IDXX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyIdexx Laboratories price target lowered to $435 from $520 at Piper Sandler
TheFlyIdexx Laboratories price target lowered to $481 from $570 at Barclays
TipRanks Auto-Generated NewsdeskIDEXX Laboratories Reports Robust Q3 2024 Performance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App